Wholesale of pharmaceutical and medical goods
ALTIBAC PRODUKTER AS
Revenue 2024
NOK 0
Operating profit
NOK −11,000
Equity
NOK 20,000
Incorporated
2020
Share capital
NOK 32,000
Key figures · 2024
Current ratio
-15.49
Equity ratio
104.9%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Return on assets (%%) | -58.3% | |
| Likviditet | ||
| Current ratio | -15.49 | |
| Working capital | 15k | |
| Soliditet | ||
| Equity ratio (%%) | 104.9% | |
| Debt-to-equity ratio | -0.05 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.